LAWRENCE, Mass., April 7, 2015 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative
dialysis products, today announced plans to release its financial
results for the first quarter ended March
31, 2015, on Wednesday, May 6,
2015, before the opening of the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on Wednesday, May 6, 2015 to discuss its first
quarter financial results. To listen to the conference call,
please dial 877-392-9886 (domestic) or 707-287-9329
(international). The call will also be webcast LIVE and can
be accessed via the investor relations section of the Company's
website at http://ir.nxstage.com.
A replay of the conference call will be available two hours
after the completion of the call through May
14, 2015. To access the replay, dial 855-859-2056
(domestic) or 404-537-3406 (international) and reference conference
ID 20785879. An online archive of the conference call can be
accessed via the investor relations section of the Company's
website at http://ir.nxstage.com.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is
a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. For more
information on NxStage and its products, please visit the Company's
website at www.nxstage.com.
Forward-Looking Statements
This Release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements
contained in this Release that are not clearly historical in nature
are forward-looking, and the words "anticipate", "believe",
"expect", "estimate", "plan" and similar expressions are generally
intended to identify forward- looking statements. The
forward-looking statements in this Release include NxStage's plan
to release its financial results on May 6,
2015. Actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors including, but not limited to, unexpected
difficulty in closing the Company's financial books for the quarter
and other factors that are discussed in NxStage's Annual Report on
Form 10-K for the year ended December 31,
2014 filed with the SEC. NxStage is under no obligation to
(and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Contact:
Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-report-first-quarter-2015-financial-results-300061350.html
SOURCE NxStage Medical, Inc.